Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
Turi
Zoltan G
ZG
D000925:Anticoagulants / Q000009:adverse effects*; D020517:Atrial Appendage; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation; D002908:Chronic Disease; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin